Riskpilot← Back to searchSign inGet full accessVEITVET APOTEK AS
ASActiveOrg 984902417Retail sale of pharmaceutical products · NACE 4773Est. 20020 employees
Revenue 2022
NOK 18,3M
+9% vs 2021
EBITDA margin
7.8%
-17% vs 2021
Equity ratio
25.2%
Financial strength
Net profit 2022
NOK 1M
-17% vs 2021
| Revenue | NOK 18,3M | +9% |
| EBITDA | NOK 1,4M | -17% |
| Net profit | NOK 1M | -17% |
| Total assets | NOK 4,5M | -1% |
| Equity | NOK 1,1M | -34% |
| Employees | 0 | — |
Legal name
VEITVET APOTEK AS
Org number
984902417
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
26. september 2002
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Company purpose
Apotekdrift.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 13 029 | 14 135 | 15 767 | 16 865 | 18 301 |
| Staff expenses | −2 227 | −2 151 | −1 825 | −2 086 | −2 571 |
| EBITDA | 770 | 1 138 | 1 868 | 1 715 | 1 430 |
| Depreciation & amort. | −165 | −161 | −155 | −158 | −133 |
| EBIT | 605 | 978 | 1 713 | 1 557 | 1 297 |
| Net financials | −4 | −2 | −1 | −1 | −4 |
| Profit before tax | 601 | 976 | 1 712 | 1 556 | 1 294 |
| Tax | 136 | 215 | 377 | 344 | 286 |
| Net profit | 465 | 761 | 1 335 | 1 213 | 1 008 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 3 734 | 4 492 | 4 498 | 4 584 | 4 546 |
| Equity | 1 430 | 1 991 | 2 026 | 1 738 | 1 146 |
| Long-term debt | 391 | 64 | 67 | 64 | 61 |
| Short-term debt | 1 912 | 2 437 | 2 405 | 2 782 | 3 339 |
| Total debt | 2 303 | 2 501 | 2 472 | 2 846 | 3 400 |
EBITDA margin
7.8%
This company
15.8%
Market median
-51% vs market
20182022
Equity ratio
25.2%
This company
38.2%
Market median
-34% vs market
20182022
Return on equity
87.9%
This company
18.4%
Market median
+378% vs market
20182022
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20182022
Asset turnover
4.03×
This company
1.12×
Market median
+260% vs market
20182022
Debt / equity
2.97×
This company
0.62×
Market median
-379% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LO Deputy Member | Deputy Member | 2004 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2004 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VEITVET APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Leif-Victor Oppedal | Deputy Member | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Seyed A Pishva | Chairman | 0 companies |